文献速递痛风与晶体性关节病

疫苗接种后痛风发作风险的前瞻性病例交叉研究

Risk of gout flares after vaccination: a prospective case cross-over study.
PubMed 文献 · Ann Rheum Dis · 2019-07-31

该研究采用在线病例交叉设计,纳入517例痛风患者,比较痛风发作前2天危险期与无发作对照期的疫苗接种暴露。结果显示疫苗接种与痛风发作风险升高相关(调整OR 1.99;95%CI 1.01至3.89),但绝对风险增幅小,应结合疫苗总体获益解读。

要点

  • 疫苗接种与痛风发作风险升高相关,调整OR 1.99。
  • 风险增幅绝对幅度小,需权衡疫苗获益。
  • 除重组带状疱疹疫苗外,其他疫苗也可能与痛风发作相关。

核心结论

  • 疫苗(除重组带状疱疹疫苗外)与痛风发作风险升高相关,调整OR 1.99(95%CI 1.01至3.89)。
  • 疫苗相关痛风发作风险绝对增幅小,应在疫苗总体获益背景下解读。

研究设计与样本

  • 在线病例交叉研究,纳入517例痛风患者(平均年龄55岁,79%男性)。
  • 比较痛风发作前2天危险期与无发作2天对照期的疫苗接种暴露。
  • 采用条件logistic回归调整协变量。

主要发现

  • 990个危险期中共有28次疫苗接种,1407个对照期中共有21次疫苗接种。
  • 疫苗接种与痛风发作风险升高相关,调整OR 1.99(95%CI 1.01至3.89)。

临床怎么用

  • 痛风患者接种疫苗时无需因痛风发作风险而回避接种,应强调疫苗总体获益。
  • 对痛风患者接种后应关注痛风发作症状,但风险绝对增幅小。

局限性

  • 研究为在线病例交叉设计,可能存在回忆偏倚和选择偏倚。
  • 疫苗接种次数较少,危险期28次、对照期21次,结果精确度有限。
  • 未明确区分疫苗种类,无法评估特定疫苗的风险差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The recombinant zoster vaccine (RZV) containing a strong non-aluminium adjuvant is associated with increased risk of gout flares, presumably via NLRP3 inflammasome activation. We tested the possibility that other vaccines may also be associated with gout flares. METHODS: We conducted an online case-crossover study of patients with gout to examine the association between vaccination and gout flares. We collected information through the Internet on exposures to potential risk factors, including vaccinations, during 2-day hazard periods prior to gout flare and 2-day control periods without a flare. Conditional logistic regression was used to adjust for covariates. RESULTS: There were 517 participants with gout (mean age 55 years, 79% male) who experienced gout flares during follow-up. There were 28 vaccinations during 990 hazard periods and 21 vaccinations during 1407 control periods. Vaccination was associated with twofold higher odds of gout flare (adjusted OR 1.99; 95% CI 1.01 to 3.89). CONCLUSION: Our findings suggest vaccines other than RZV are associated with increased odds of gout flares, potentially through a shared pathogenetic mechanism like NLRP3 inflammasome. However, the absolute magnitude of increased odds of gout flares with vaccinations remains small and must be interpreted within the context of the overwhelming benefits of vaccinations.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Yokose C, McCormick N, Chen C, et al. Risk of gout flares after vaccination: a prospective case cross-over study. Ann Rheum Dis. 2019. PMID: 31366470. doi:10.1136/annrheumdis-2019-215724

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。